Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-07
DOI
10.1038/s41467-017-01572-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD4 + CD25 + regulatory T cells in tumor immunity
- (2016) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
- (2016) Katelyn T. Byrne et al. Cell Reports
- Intratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression
- (2015) Mauricio Urquiza et al. HUMAN GENE THERAPY
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Evolving treatment options for melanoma brain metastases
- (2015) Thankamma Ajithkumar et al. LANCET ONCOLOGY
- Cancer-fighting viruses win approval
- (2015) Heidi Ledford NATURE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Management of Multiple Melanoma Brain Metastases
- (2015) Sharad Goyal et al. JAMA Oncology
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy
- (2014) Chung-Pu Wu et al. Acta Pharmaceutica Sinica B
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression
- (2012) J Melo-Cardenas et al. CANCER GENE THERAPY
- Gene Immunotherapy of Chronic Lymphocytic Leukemia: A Phase I Study of Intranodally Injected Adenovirus Expressing a Chimeric CD154 Molecule
- (2012) J. E. Castro et al. CANCER RESEARCH
- Recent developments on immunotherapy for brain cancer
- (2012) Derek A Wainwright et al. EXPERT OPINION ON EMERGING DRUGS
- Melanoma brain metastasis: overview of current management and emerging targeted therapies
- (2012) Ekokobe Fonkem et al. Expert Review of Neurotherapeutics
- In this issue: Harnessing Immunity against Difficult Targets, through the CD40-CD40L Pathway
- (2012) Richard S. Kornbluth et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Agonistic Antibody to CD40 Boosts the Antitumor Activity of Adoptively Transferred T Cells In Vivo
- (2012) Chengwen Liu et al. JOURNAL OF IMMUNOTHERAPY
- T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
- (2010) Y. Zhu et al. JOURNAL OF IMMUNOLOGY
- CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893
- (2010) Anusha Kalbasi et al. JOURNAL OF IMMUNOTHERAPY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now